Although not widely recognized clinically, evidence of peripheral neuropathy in patients with chronic venous insufficiency (CVI) has been reported by several investigators. 1-3 A commonly described clinical characteristic of venous ulceration is less severe pain and discomfort than expected. Minor trauma, such as scratching from pruritus, is often responsible for the initiation of venous ulceration. British investigators demonstrated neurologic abnormalities on the foot of limbs with CVI, an area not normally associated with skin breakdown in patients with venous insufficiency. 1,2 The supramalleolar area, which is commonly prone to ulceration, was not assessed.
Accordingly, we evaluated and compared a group of limbs with mild (CEAP class 2) and severe (CEAP class 5) CVI. The patients were examined for clinical evidence of neuropathy and severity of neuropathy, if present. Sensory thresholds were determined at nine sites on the upper and lower limbs. These sites included both those areas usually associated with venous insufficiency and those areas usually not affected by venous insufficiency.
METHODS
The patients underwent evaluation for CVI with clinical examination and were stratified according to the CEAP clinical classification. [7] [8] [9] Etiology, anatomy, and pathophysiology were further characterized with duplex ultrasound scanning and air plethysmography (APG). Complete neurologic examinations were conducted by an experienced, board-certified neurosurgeon with special expertise in peripheral nerve evaluation. The neurologic examination included the evaluation of deep tendon reflexes, motor strength, and vibratory, light touch, and proprioceptive sensation. Cutaneous sensory thresholds were determined with Semmes-Weinstein filaments at a total of nine sites: seven on the lower limb and two on the ipsilateral palmar surface (Fig 1) . The sites were selected to assess the anatomic areas most commonly affected by the skin changes of CVI and to assess different dermatomes and peripheral cutaneous nerve distributions. In the palm, thenar and hypothenar thresholds were measured as internal controls.
Subjects were excluded if other conditions associated with known peripheral neuropathy precluded adequate analysis (ie, diabetes mellitus, ethanol abuse, vitamin deficiencies). Likewise, limbs with prior surgery, such as saphenectomy or open fracture reductions, were excluded. Because limbs with open ulceration (CEAP class 6) are difficult to evaluate objectively, patients with this condition were excluded. The comparison was conducted between 12 patients with CEAP class 5 disease (healed ulceration) and 11 patients with CEAP class 2 disease (varicose veins without skin changes, edema, or ulceration).
Sensory thresholds were measured with a pressure aesthesiometer consisting of 20 nylon filaments calibrated to buckle on application of a graduated longitudinal force (F) ranging from 4.5 mg to 447g. Pressure applied by Semmes-Weinstein filaments is expressed as the log 10 (F in mg) (10) . This logarithmic scale expresses the threshold as a linear relationship with corresponding values ranging from 1.65 to 6.65. 10 For sensory examination, the patient was blocked from visual observation during the applica-tion of the test filament and was requested to verbalize the sensation of touch and its specific location. The testing was begun with an application of force sufficient to dimple the skin, thereby "pinning" both ends of the filament. The test filament was considered sensed when the appropriate verbal response was elicited at the bending of the "pinned" test filament shaft. Initially, the largest and most rigid filament (6.65) was applied to the palmar surface of the hand to show the expected sensation before beginning the actual threshold determinations. Beginning with the largest filament, each site was evaluated in descending order until the smallest filament was correctly identified by the subject. In equivocal situations, the process was repeated with descending and ascending strength filaments to arrive at a consistent result. Each unidentified filament was presented three times before it was recorded as not sensed. Both ascending Table I . November 1999 and repetitive examinations were perfomed as an internal cross check at the site. The examiner had to carefully avoid the stimulation of the hair follicles or the dragging of the tip of the filament on the skin because inadvertent stimulation would falsely lower the sensory threshold. 11 The filament examinations were performed independently by two examiners.
Neurologic examinations of the extremity were performed by our neurosurgical collaborator. Specific attention was directed to the evaluation of vibration (with a 128-Hz tuning fork), light touch determined with pin prick, patellar and achilles deep tendon reflexes, proprioception or position sense, and motor strength. The findings were assigned a score from 0 to 3 that respectively indicated absence of the finding, diminished from normal, normal, or stronger than normal. Finally, the filaments were applied to determine the sensory threshold of the extremity and to localize and quantitate the changes in this threshold.
The non-invasive examination of the lower extremity was conducted according to accepted standards. [12] [13] [14] [15] A duplex scan survey evaluated the deep venous system for evidence of prior thrombosis or obstruction. Valves were considered to be incompetent if reflux continued for more than 0.5 seconds. Perforator veins in the thigh or calf were noted. 12, 14 APG was performed to evaluate the severity of the venous insufficiency and was reported as the venous filling index. Normal results were considered to be less than 2.0 mL/s. 13, 15 The data were analyzed and the groups were compared with the Wilcoxon rank sum test. The neurologic scores were analyzed with the exact text for trend in ordered categories. Analyses were performed with True Epistat (Epistat Services, Richardson, Tex) and StatXact (Cytel Software Corp, Cambridge, Mass) software, with statistical significance accepted when the P value was less than .05. The project was evaluated and approved by the Institutional Review Board of the Veterans Affairs New Jersey health care system.
RESULTS
The sensory thresholds at the most common site of venous ulceration-just proximal to the medial malleolus-were significantly different between limbs with CEAP 2 (median, 3.61) and CEAP 5 (median, 4.65) disease (Table I) . A significant difference also was present at the following four sites: just proximal to the lateral malleolus, the proximal medial and lateral calf, and the thigh. The remainder of the tested sites were not different between limbs with CEAP 2 and CEAP 5 CVI (Table I) . Profoundly abnormal examination results were recorded in three individuals with class 5 disease who were unable to appreciate the presence of even the thickest, most rigid filament.
Objectively, sensory abnormalities coincided with the extent of trophic changes and did not reflect specific dermatomal or cutaneous nerve distributions. A representative skin biopsy taken from a limb with severe CVI shows marked perineural degeneration, edema, and collagen replacement ( Fig 2) .
Vibration, ankle and patellar deep tendon reflexes, and light touch and pinprick senses were diminished in limbs with CEAP 5 disease. Statistical analysis results of the assigned values in the two groups showed a significant difference in each of these categories (Table II) . The motor evaluations and the proprioceptive sense were not different between groups.
The least sensitive filament threshold was determined by each of two independent examiners for each limb. A significant difference between the thresholds was observed in the limbs with CEAP 2 CVI in comparison with the limbs with CEAP 5 CVI (Table III) . Rank correlation results between the examiners' sensory protection would translate into an increased propensity for skin breakdown and ulcer formation. As with diabetes or leprosy, diminished sensory perception may contribute to skin breakdown in association with other sources of injury (ie, pressure, scratching). The prospective identification of limbs at risk would provide a logical opportunity for the follow-up evaluation of this potential risk factor for ulcer recurrence. Although the appropriate level of sensory impairment that would be associated with such increased risk is undetermined at this time, the ease and convenience of this examination lends itself to screening at an initial examination for the planning of the treatment of CVI.
The techniques of filament application may have an influence on the results. We used the methodology as described by Levin et al. 10 The thresholds in the palm and the foot were similar in limbs with CEAP 2 and CEAP 5 CVI. The normal sensory thresholds for the lower limb above the malleolus are not available from the literature. Holewski et al 4 reported foot thresholds in healthy individuals, two assessments showed a strong agreement on the relative magnitude of the thresholds (Spearman rank correlation: r = 0.75; P = .0002).
Although the limbs were assigned a CEAP class on the basis of the clinical examination results, the duplex scanning and APG examination results suggested that the non-invasive abnormalities increased with the increased clinical severity of CVI. The mean number of incompetent valve segments differed significantly between CEAP 2 and CEAP 5 CVI. Superficial incompetence predominated in limbs with class 2 disease, and limbs with class 5 disease were remarkable for combined superficial, deep, and perforating vein incompetence. Post-thrombotic abnormalities were recognized in six of the 12 limbs with class 5 disease. However, neither duplex scan nor outflow fractions indicated a component of venous obstruction. Physiologically, the two groups were similar: age, ankle brachial indices, and reflux (venous filling index) were not significantly different between the CEAP 2 and CEAP 5 groups (Table IV) .
DISCUSSION
Measurement of sensory threshold testing confirmed the presence of sensory abnormalities in the trophic areas of CVI skin. Localization to supramalleolar skin is an important addition to previous observations. The magnitude of the sensory impairment observed in the limbs with CEAP 5 disease (5.31 and 5.07; Table III ) was similar to that reported as a significant sensory threshold in diabetes or leprosy (5.07). [4] [5] [6] 16 In prospective studies, the inability of the subject with diabetes to appreciate the application of a 5.07 filament was a significant risk factor and predicted subsequent ulceration of the plantar surface skin of the foot. 4, 6 Because the neuropathy is localized to the supramalleolar skin, the individual with CVI is not prone to the development of ulceration on the plantar or dorsal foot. Unlike the subject with diabetes, the distribution of the neuropathic abnormality is localized and does not manifest a stocking or glove distribution. Whether the same risk implications of impaired cutaneous sensation will hold true for the limb of the patient with CVI will, of course, require prospective evaluation.
Currently, it is not known whether the described neuropathy contributes to injury. However, we do know that a specific level of neuropathy will lead to an increase in skin lesions in diseases that produce a profound peripheral neuropathy (ie, leprosy, diabetes). 4, 5 Although the skin of the leg is not subject to the same pressures as the plantar surface of the foot, it is logical to hypothesize that the diminished November 1999 of which (his sites 8 and 9) correspond with our sites 1 and 2. Holewski and colleagues 4 also reported a dorsal web space threshold of 3.87 ± 0.07 and a dorsal foot threshold of 3.81 ± 0.07. These values were similar to those values reported on the dorsal foot at our sites 1 and 2 (Table I) . The normal sensory thresholds in the hand are expected to range from 2.44 to 2.83. 11, 17 The palmar sensory thresholds are also similar to those thresholds reported at our sites 8 and 9 (Table I) . Our thresholds in the palm may be slightly higher because the tips of the fingers are considered to be the most sensitive site in the hand.
Widely thought to be relatively pain free, cutaneous ulceration from venous insufficiency is often managed in outpatient clinics. Point-specific pain may represent exposed cutaneous nerve endings, and diffuse pain is frequently associated with cellulitis, inflammation, and infection. Pain from exposed nerve endings is only relieved with the restoration of skin coverage, but the diffuse inflammatory compo-nent often subsides with the commencement of efficacious therapy-elevation, antibiotics, and compression. Previous investigations have suggested the presence of a neuropathic component to CVI. 1, 2 Morphologic study results from our institution have identified the destruction of cutaneous nerve fibers in areas subjected to chronic venous hypertension (Fig 2) . Parkhouse and LeQuesne 18 described the vasodilatory flare response on the plantar surface of the foot and used the technique to identify abnormalities in the nociceptive C fibers, which are associated with both sensation and the reflex response to wound healing. The flare is an axon reflex vasodilation, the intensity of which is diminished with local anesthesia or peripheral neuropathy. 18 Ardron et al 2 evaluated the dorsal surface of the foot in 15 limbs with severe CVI with the vasodilatory flare. Shami et al 1 compared 40 patients with severe CVI (class 4 or higher) with patients with healthy limbs. The threshold to warming and to vibration (Ohio Bio-Thesiometer, Newbury, Ohio) was significantly increased in the CVI group. That group also identified abnormalities of vibration and light touch. 1 These investigators also used the vasodilatory flare, and both reported their observations on the foot. Taheri et al 3 suggested the presence of a diffuse neuropathy after electromyographic examinations and microscopic examinations of four calf muscles and two sural nerves. Unlike the Semmes-Weinstein filaments, these methods require special equipment and are not conducive to widespread screening examinations.
Like the results of these investigators, our observations suggest that the neurologic dysfunction involves more than just cutaneous nerve fibers. Although clinical expectations would implicate the cutaneous sensory manifestations, a wider scope of peripheral nerve dysfunction was observed encompassing joint innervation (deep tendon reflexes) and sensory modalities. Thus, it is possible that venous insufficiency also affects the subfascial peripheral nerve trunks. Deep tendon reflexes are known to diminish with age, which may account for the decreased response observed in the group with class 2 disease. 19 Because the mean ages of the two groups were not different, the conclusions should not be affected. Although the role of the neurologic specialist was objective reporting of the clinical neurologic examination, the elimination of visual clues that defined the two groups may have been unavoidable. Although motor strength was intact to clinical examination, we have previously reported an association between a diminished ankle range of motion, decreased calf pump function, and severe CVI, which may also be related. 13 Thus, in addition to the demonstrated cutaneous sensory impairment, we have also confirmed the diffuse peripheral nerve dysfunction reported by other investigators. [1] [2] [3] Several theories have been proposed to explain the injury resulting from venous insufficiency. These include the fibrin cuff and leukocyte trapping hypotheses, both of which are thought to represent an inflammatory response to chronic ambulatory venous hypertension. 20 Although the actual mechanism of the neuropathy is unknown, it is not unlikely that the same processes may be affecting the peripheral nerve trunks in limbs with severe venous insufficiency. Although it is clearly not the primary risk factor, cutaneous sensory impairment in the lower extremity may represent an important clinical variable predisposing to recurrence of derrmal ulceration. The duplex scan and clinical examination results objectively confirm the presence of venous insufficiency in groups that do not differ significantly in terms of age or arterial abnormality. The groups both had substantial reflux, although deep vein valvular abnormalities were more extensive in the class 5 group. This study supports the concept of localized neurologic injury at the site of maximal cutaneous changes in limbs with venous hypertension, and this observation may prove important in the future treatment and management of venous ulceration.
We thank Dr Joan Skurnick for advice and assistance with the statistical analysis and Dr David DeFouw for assistance with preparation of the photomicrograph. Dr Gregory L. Moneta (Portland, Ore). Dr Padberg and his colleagues are to be congratulated for bringing before the American Venous Forum the concept of a measurable peripheral neuropathy as a component of chronic venous insufficiency. I believe that they have adequately demonstrated that a neuropathy of some sort does exist in these patients. I think it is important to keep in mind that clearly the target organ in chronic venous insufficiency is the skin. There is clearly an anatomic and functional microangiopathy of the cutaneous capillaries and lymphatics of the perimalleolar region in patients with chronic venous insufficiency and lipodermatosclerosis. It is not surprising, indeed I think it should be expected, that the cutaneous nerves of lipodermatoslcerotic skin should, along with the capillaries and lymphatics, also be affected by the cutaneous fibrosis characterizing lipodermatosclerosis.
I have several questions for Dr Padberg. I wonder why a control group without venous disease was not studied. Without controls we really do not know whether the socalled neuropathy of chronic venous insufficiency is a chicken or an egg problem.
Secondly, did you control for edema? We all know that patients with significant swelling in their feet and legs will complain of altered sensation in the region of the swelling. Patients with CEAP 2 disease by definition have no edema, and patients with CEAP 5 disease may have severe edema. How can we be sure that the decreased sensation observed about the ankles in the patients with CEAP 5 disease is not merely a reflection of increased edema and not really the result of a true neuropathy?
Also, I cannot understand conceptually why patients with CEAP 5 chronic venous insufficiency should have decreased deep tendon reflexes as compared with patients with CEAP 2 disease. Is there a neurologic pathway that I am unaware of that affects cutaneous nerves about the ankle and the calf but not on the foot and also affects the spinal reflex arc at the knee?
Finally, I enjoyed this paper very much. Its ultimate value may be to lead to predicting which patients with chronic venous insufficiency are at risk for the development of an ulcer as a result of their inability to protect themselves from minor trauma about the ankle. In this respect, the testing described by Dr Padberg and colleagues in patients with chronic venous insufficiency may be analogous as he has alluded to testing for altered sensation in the feet of patients with diabetes. This may help identify those who are at risk for venous ulceration.
I appreciate the opportunity to discuss this paper and congratulate the authors on their fine work. Thank you.
Dr Frank T. Padberg, Jr. Thank you, Dr Moneta.
In answer to question one, why did we use no true controls? The answer is that this is in process. In the presentation, I alluded to our desire to evaluate healthy limbs and patients with CEAP 4 disease, and I think that would give us the opportunity then to add a greater value to our conclusions to where this may in fact represent a severity of disease. With the recognition that hemodynamic significance was not shown in the final cohort of patients, I agree that further study will be appropriate.
With regard to edema, I would say first of all that none of these patients had edema at the time of their examinations. Very few of them continued to have long-term edema, but one of the other questions that would normally come up in this situation is the effect of the local scar from the healing of an ulcer and whether that may have had some impact as well. I think the fact that it is a more global phenomenon instead of just the medial malleolar site certainly implies that chronic venous insufficiency is the cause. Secondly, oftentimes these patients will have thickened skin and other abnormalities in the local area that could give an abnormal reading with the filaments. We tried not to evaluate patients who had thickening and eschar present, and that is one of the reasons that we waited until they had stable healing and had reached a point where that was no longer an issue.
Finally, I do not know of another nerve pathway or spinal reflex arc. However, I do think that the fact that we see changes in areas where there are not trophic changes adds to the speculation that this is a more global phenomenon in the limb with chronic venous insufficiency than it is to just the local area where we most commonly see the secondary side effects.
Dr J. Leonel Villavicencio (Washington, DC). I would like to join Dr Moneta in congratulating you, Dr Padberg, for your interesting study. I just wanted to share with you observations that I have made in the course of the management of patients with congenital vascular malformations of venous predominance. In operating on these patients, I have noticed that the sural nerve, for example, is completely full of veins, congested. I have confirmed this observation in different areas of the leg and these individuals. Sometimes these nerves are so large with tortuous varicose veins and vena nervorum that I am sure that this is a cause for problems with pain as well as changes in the sensation of these individuals.
Thank you. Dr Padberg. Thank you for sharing your immense experience. The manuscript offers a reference to specific microscopic evidence of neuropathic changes in the sural nerves. I would also append a comment relating our find-ings to those of diabetic microangiopathy, which probably involves the neural sheath as well.
Dr Robert Kistner (Honolulu, Hawaii). I would certainly like to congratulate you on an important study and a good contribution. Mine is a different question, and it is about the use of the CEAP. I think that you are using CEAP to point out the most serious level of involvement. Had you used CEAP to catalogue all of the manifestations, we would now know how many patients had swelling and induration in their legs. So the question is, do you have that information? In other words, do you have the varicose veins, the swelling, and the induration to go along with the CEAP 5 group? Dr Padberg. I have listed the specific valves that were involved, if this is what you are referring to. Six of the limbs were post-thrombotic. The limbs with class 5 chronic venous insufficiency had a higher frequency of incompetent valves. The information is summarized in the manuscript.
CORRECTION
In the Table of Contents of the October 1999 issue of the Journal of Vascular Surgery, an error in production caused the first section of articles to be incorrectly labeled "Original Articles from the American Venous Forum." These articles should have been under the heading of "Original Clinical Science Studies." The papers from the American Venous Forum were not published in the October 1999 issue. We regret any confusion that may have been caused by this error.
